Intracellular membrane trafficking along endocytic and secretory transport pathways plays a critical role in diverse cellular functions including both developmental and pathological processes. Briefly, proteins and lipids destined for transport to distinct locations are collectively assembled into vesicles and delivered to their target site by vesicular fusion. SNARE (soluble N-ethylmaleimide-sensitive factor-attachment protein receptor) proteins are required for these events, during which v-SNAREs (vesicle SNAREs) interact with t-SNAREs (target SNAREs) to allow transfer of cargo from donor vesicle to target membrane. Recently, the t-SNARE family member, syntaxin-6, has been shown to play an important role in the transport of proteins that are key to diverse cellular dynamic processes. In this paper, we briefly discuss the specific role of SNAREs in various mammalian cell types and comprehensively review the various roles of the Golgi- and endosome-localized t-SNARE, syntaxin-6, in membrane trafficking during physiological as well as pathological conditions.
THE ROLE OF SNARE
S (SOLUBLE N-ETHYLMALEIMIDE-SENSITIVE FACTOR-ATTACHMENT PROTEIN RECEPTORS) IN MEMBRANE TRAFFICKING
SNAREs are tail-anchored membrane proteins involved in the vesicle fusion process. There are 38 distinct SNAREs [25 t-SNAREs (target SNAREs), nine v-SNAREs (vesicle SNAREs) and four unclassified SNAREs], which have been identified in mammalian cells [1,2]. Each performs specific functions towards the delivery of cargo to specific destinations; together, these proteins ensure that recycling is efficient, i.e. that all the components necessary for successive rounds of transport are present [1,2]. SNARE family members are characterized by an evolutionarily conserved central coiled-coil SNARE motif that mediates the interaction of SNARE–SNARE proteins, which is the critical function of SNAREs. Functionally, SNAREs are classified as ‘v-SNAREs’ found on the vesicle membrane and ‘t-SNAREs’ found on the target membrane. Vesicular transport is driven by specific interactions between specified v-SNAREs and their cognate t-SNAREs. SNAREs are additionally classified on the basis of structure into ‘Q-’ or ‘R-SNAREs’ depending on the presence of a conserved glutamine or arginine residue respectively within the conserved SNARE domain. Based on sequence analysis, most of the v-SNAREs are classified as R-SNAREs, whereas syntaxins and SNAP-25 (25-kDA synaptosome-associated protein) are classified as Q-SNAREs (Figure 1a). The Q-SNAREs are further subdivided into ‘Qa-’, ‘Qb-’ and ‘Qc-SNAREs’, on the basis of the relative position of their SNARE motifs in the assembled trans-SNARE complex formed by union of the v- and t-SNARE during membrane fusion [1,3]. Most SNAREs are also transmembrane proteins with a hydrophobic C-terminal domain, with the exception of SNAP-25. SNAP-25 exists in two different forms, cytosolic and membrane bound, which are distinguished by the presence of the post-translational modification, palmitoylation. Newly synthesized, non-palmitoylated SNAP-25 remains soluble whereas mature, palmitoylated SNAP-25 accumulates on intracellular membranes . Each cell type is known to express different combinations of SNARE family members selectively distributed on organelles and membrane domains. Depending on the physiological requirements of each cell type, the repertoire and function of its SNARE proteins can be as diverse as the transport of receptors to and from the cell surface, constitutive- and induced-secretion of immune and inflammatory mediators and the release of neurotransmitters [5–7]. Hormones are also released via SNARE-mediated exocytotic fusion events [8,9]. In the following section, we discuss the specific role of SNAREs in various cell types.
The domain structure of SNAREs and the itinerary of syntaxin 6 involvement in vesicle fusion events
The human immune system requires a highly dynamic and efficient intracellular transport system for the timely and targeted delivery of key immune molecules, including cytokines, chemokines and lysosomal enzymes, to their respective target sites [10,11]. Vesicles enclose these molecules; undergo budding, transport and tethering; and finally fuse with the plasma membrane to release their contents. A variety of immune cells circulate in the body and a large set of SNARE proteins has evolved to accommodate the protein transport needs of these distinct populations of immune cells. Each immune cell type may use a distinct subset of SNAREs depending on the cell's function within the immune system.
SNAP-23 (23-kDa synaptosome-associated protein) has been shown to be involved in the transport and secretion of immunoglobulins from human plasma cells which indicates that SNAREs have a function in the humoural immune response . Platelets are rich in lysosome-containing granules whose contents are required for blood clotting and inflammation at the site of injury. Release of the granular contents requires SNARE complexes that consist of the t-SNAREs, syntaxin-4 or syntaxin-2; SNAP-23; and the v-SNAREs, VAMP3 (vesicle-associated membrane protein 3) and VAMP8 [13–16].
Neutrophils contain several types of granules containing inflammatory and antimicrobial products which require specific sets of SNARE proteins for their delivery to cell surface and to other organelles . When neutrophils are activated, VAMP1- or VAMP2-containing granules [as well as the so-called SGs (specific granules) and GGs (gelatinase granules)] are translocated to the cell surface where their v-SNAREs associate with the plasma membrane-associated t-SNAREs, syntaxin-4 and SNAP-23, to form trans-SNARE complexes (such as syntaxin-4–SNAP-23–VAMP1 and syntaxin-4–SNAP-23–VAMP2) that modulate granule secretion [17–20]. Although present on all granules in neutrophils, VAMP7 preferentially functions in the release of contents from azurophilic granules. Similar to other v-SNAREs in neutrophils, VAMP7 on azurophilic granules couples with syntaxin-4 on the plasma membrane; however, SNAP-23 is not involved in the fusion and release of azurophilic granules and the alternative Q-SNARE for this role remains to be identified [19,21]. The v-SNARE, syntaxin-7, located in the major granules of neutrophils, functions in the exocytosis of azurophilic granules from activated neutrophils .
SNAREs expressed by eosinophils, whose granules contain substances that can contribute to the allergic inflammatory response, are similar in type to those expressed by neutrophils. Eosinophils induced to secrete the contents of their granules by IFN-γ (interferon γ) express syntaxin-4, SNAP-23 and SNAP-25 on their plasma membrane; binding of these t-SNAREs to granules expressing VAMP2 results in eosinophil degranulation and the subsequent release of the granule contents from the cell [23,24]. Mast cells, which play a major role in both allergic and non-allergic diseases, express SNAP-23, syntaxin-4, VAMP7 and VAMP8 which are known to be required for the release of stored histamine. These proteins are also involved in chemokine release, with syntaxin-3 and SNAP-23 crucial for the release of all chemokines and other SNAREs such as syntaxin-4, syntaxin-6 and VAMP8 participating in the release of only selected chemokines [25,26]. Mast cells also release cytokines in combination with non-canonical SNARE isoforms, such as complexin II and synaptotagmin [27,28]. Macrophages, which move towards the site of inflammation via chemotaxis, require the VAMP3–syntaxin-4–SNAP-23 SNARE complex to bring VAMP3-expressing recycling endosomes to the plasma membrane; their cargo is essential for expansion of the plasma membrane which is in turn required for macrophage adhesion and spreading . These cells also require syntaxin-11 which mediates trafficking from late-endosomes to lysosomes by regulating the Vti1b-dependent SNARE complexes, syntaxin-6–syntaxin-7–Vti1b and syntaxin-7–syntaxin-8–Vti1b .
Components of SNARE complexes are also involved in the development and function of neuronal cells. Among the SNAREs studied (VAMP2, SNAP-25A and syntaxin 1A), VAMP2 promotes neurite elongation while SNAP-25A stimulates neurite sprouting while syntaxin 1A does not have any neuronal effects [31,32]. Synaptic vesicle fusion with the target membrane in neuronal cells is triggered by Ca2+ signalling and requires an interaction between syntaxin-1 and SNAP-25 located at the plasma membrane and the VAMP2 or synaptobrevin present on the synaptic vesicles [7,33]. In addition, synaptotagmins are also involved at the fusion step along with SNAREs during synaptic vesicle fusion . Synaptotagmin-1 is the Ca2+ sensor for membrane fusion and its function is linked to the SNARE complex and is the only molecule besides the SNAREs that has been shown to have a direct effect on the kinetics of exocytosis . In synaptotagmin-1, Ca2+ binding results in an electrostatic switch that changes the net charge from negative to positive and enables the Ca2+ binding domain to interact with and insert into the negatively charged membranes [36,37]. Furthermore, synaptotagmin-1 Ca2+ binding domains bind SNAREs in a Ca2+-regulated manner . The Ca2+-dependent SNARE- and membrane-binding activities of synaptotagmin-1 are both essential for triggering exocytosis [39–41]. SM (Sec1/Munc18-like) proteins and complexin have also been identified that are required for Ca2+-dependent exocytosis at the synapse . The oligodendrocytes that form the myelin sheath surrounding axons of the CNS (central nervous system) neurons require syntaxin-3, syntaxin-4, SNAP-23 and VAMP3 during vesicle fusion for the addition of proteins and lipids to growing myelin membrane . Syntaxin-1, SNAP-25 (at the target or plasma membrane) and the v-SNARE, VAMP2, on secreting vesicles are required for Ca2+-triggered neuroexocytosis. SNAP-25 and syntaxin-1 are also involved in voltage-gated calcium channel function where they play a role in modulating steady-state inactivation of channel opening. In particular, SNAP-25 and the SNAP-25b isoform expressed in both mature glutamatergic and GABAergic (γ-aminobutyric acid) neurons serve as mediators of fast synaptic communication by regulating action potential-dependent neurotransmission in excitatory and inhibitory circuits required for brain function . Syntaxin-12/13 is enriched in the brain and is localized in the recycling endosomes of the neuron, thus it has been shown to have a role in modulating the dynamics of neurotransmitter receptors. Syntaxin-12/13 interacts with NEEP21 (neuron-enriched endosomal protein of 21 kDa); this complex is also associated with the AMPA (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptor subunit, GluR2, and GRIP1 (glutamate receptor interacting protein 1), which plays an important role in receptor trafficking .
Given the central role that SNARE proteins play in the CNS, it is likely that their misregulation is involved in various CNS-related diseases. Consistent with this notion, SNARE proteins have been shown to be involved in γ-secretase function [which is impaired in AD (Alzheimer's disease)], schizophrenia and various other mental illnesses [45–49]. Although an unconventional mechanism (distinct from that used by the CNS) is utilized in ribbon synapses (in hair cells of cochlea) and specialized retinal synapses (between the photoreceptor and bipolar cells) for neurotransmitter release, these synapses still require a host of SNARE complex proteins for sustained release of neurotransmitters [50,51].
Endocrine tissues and epithelial cells
SNARE complexes are also critical for the release of secretory granules in a variety of epithelial cells located in endocrine tissues. For example, the SNARE proteins SNAP-23, SNAP-25, syntaxin-1 and VAMP1–3 are expressed in human parathyroid tissues. Among all normal and cancerous parathyroid gland samples studied, SNAP-23 and VAMP1–3 were expressed at similar levels whereas SNAP-25 and syntaxin-1 were not expressed in normal samples. Notably, in 20% of chief cell adenoma and 45% of parathyroid carcinoma samples, both SNAP-25 and syntaxin-1 were expressed . These data suggest that the SNARE proteins SNAP-23 and VAMP1–3 play a role in stimulus-secretion coupling and exocytosis of parathyroid hormone under normal physiological conditions while SNAP-25 and syntaxin-1 play tumour-specific roles.
SNARE proteins are also involved in insulin secretion by β-cells of the pancreas [8,53]. Studies of insulin exocytosis in isolated pancreatic islets of Type 2 diabetic patients and non-diabetic controls revealed that the expression of SNARE proteins and SNARE-modulating proteins (including syntaxin-1A, SNAP-25, VAMP2, nSec1, Munc13-1 and synaptophysin) are decreased in samples from diabetic patients, possibly contributing to the impaired insulin secretion in patients with Type 2 diabetes . This study illustrates the importance of SNARE protein function in pancreatic secretion of insulin under normal as well as diabetic conditions.
Mammary epithelial cells, which are responsible for producing milk after parturition, express a distinct class of SNARE proteins. In both whole mouse mammary glands and purified mouse mammary epithelial acini, t-SNAREs (SNAP-23, syntaxin-6, syntaxin-7 and syntaxin-12/13) and v-SNAREs (VAMP4 and VAMP8) coordinate the secretion of casein and milk fat globules into the mammary duct .
Thus, by facilitating the uptake, secretion and recycling of key biological molecules, SNARE proteins maintain cellular inventory and facilitate various dynamic cellular processes described above. In the next section, we focus on the SNARE family member syntaxin-6 and its roles in the context of additional cellular conditions.
SYNTAXIN-6 MEDIATED REGULATION OF MEMBRANE TRAFFICKING AT VARIOUS SUBCELLULAR LOCATIONS
Syntaxin-6 is composed of an N-terminal domain followed by a SNARE motif and a single C-terminal membrane anchor. Due to the primary structure and high homology to several syntaxin members in the SNARE motif, syntaxin-6 was first classified as a Qa-SNARE (Figure 1a). Syntaxin-6 also shares significant sequence homology with the C-terminal SNARE motif of SNAP-25, which led to the classification of syntaxin-6 as a member of the SNAP-25 family rather than the syntaxin family. As such, syntaxin-6 is known to interact with various SNAREs as well as components of other trafficking machinery . In most cell types, syntaxin-6 is found in the TGN (trans-Golgi network) and EEs (early endosomes); however, in macrophages and neutrophils syntaxin-6 is also found in secretory vesicles and the plasma membrane respectively. The SNARE motif of syntaxin-6 leads to its localization to the TGN by retention via interaction with TGN-resident molecules. Syntaxin-6 also has one tyrosine-based sorting motif (YGRL at position 140–143 between the N-terminal domain and SNARE motif), which regulates retrograde transport of syntaxin-6 from the plasma membrane to the TGN (Figure 1b) . Syntaxin-6 forms complexes with the v-SNARES, α-SNAP, VAMP2 and VPS45 (vacuolar protein sorting 45); interaction of VPS45 with the syntaxin-6-containing SNARE complex is mediated by the N-terminal short sequence of syntaxin-16 [58–60].
In human fibroblasts, syntaxin-6 regulates post-Golgi transport and delivery of the membrane microdomain components such as GM1 ganglioside (glycosphingolipid) and caveolin-1 to the plasma membrane . Caveolae are flask-shaped endocytic structures that are enriched in membrane microdomain components and are abundant in fibroblasts, ECs (endothelial cells) and adipocytes . Caveolar endocytosis has been shown to be dependent on microdomain composition at the plasma membrane . Hence, alteration of surface membrane microdomain lipid and protein composition via inhibition of syntaxin-6 function was found to decrease the internalization of cargo molecules by caveolae . In addition, retrograde transport of membrane microdomain-associated glycosphingolipids and LDL (low-density lipoprotein)-derived cholesterol to the TGN require syntaxin-6 [64,65].
Both endocrine and neuroendocrine cells contain MSGs (mature secretory granules), which are critical storage compartments for hormones and neuropeptides. These structures are generated by homotypic fusion among ISGs (immature secretory granules), an event that requires syntaxin-6 . However, none of the syntaxin-6-cognate SNARE partners were involved in such ISG–ISG fusion processes . Such homotypic fusion requires functional syntaxin-6 on donor as well as on acceptor membranes, suggesting that t–t-SNARE interactions, may drive fusion of ISG membranes. However, SNAREs that regulate MSG exocytosis – such as syntaxin-1, SNAP-25 and VAMP2 – do not contribute to this homotypic fusion. ISG-localized synaptotagmin IV interacts with syntaxin-6 and participates at different stages rather than acting synergistically at the same stage of ISG–ISG fusion .
EEs fuse homotypically as well as heterotypically with LEs (late endosomes) or lysosomes, for efficient recycling and degradation of cargo molecules. Syntaxin-6 along with other endosomal SNAREs, syntaxin-13, Vti1A and VAMP4 have been shown to promote liposome fusion in vitro . Homotypic fusion between EEs requires the PI3P (phosphatidylinositol 3-phosphate)-binding protein, EEA1, an effector of Rab5. Syntaxin-6 and EEA1 were found to co-localize extensively on EEs, although syntaxin-6 is present in the TGN as well [64,69]. Syntaxin-6 interacts directly with the C-terminal-binding site of EEA1 which overlaps with that of Rab5 and participates in the in vitro fusion of EEs [64,70]. These studies indicate that SNAREs can interact directly with Rab effectors and participate in endocytic membrane trafficking. Indeed, depletion of syntaxin-6 in ECs resulted in inhibition of endocytic recycling of α5β1 integrin .
Chlamydia trachomatis is an obligate intracellular pathogen; syntaxin-6 has been shown to be involved in the formation of the parasitophorous vacuole, an inclusion that is required for replication of the pathogen. Host syntaxin-6 is recruited to the chlamydial inclusion membrane protein; although the exact function of syntaxin-6 at the inclusion membrane remains to be defined, it is believed that it may mediate specific vesicle fusion events required for maintaining the chlamydial inclusion . Another intracellular pathogen Salmonella has been shown to acquire LAMP1 (lysosome-associated membrane protein 1) on phagosomes from the TGN via Salmonella effector protein-mediated recruitment of host syntaxin-6, probably to stabilize their niche in macrophages .
Syntaxin-6-mediated membrane trafficking appears to involve many proteins that are not members of the SNARE complex but bind to syntaxin-6 directly. For example, syntaxin-6 is directly bound by MARCH-II (membrane-associated RING-CH-II), a mammalian E3 ubiquitin ligase family member that localizes to endosomal vesicles and the plasma membrane . MARCH-II regulates the cellular distribution of syntaxin-6 as well as protein trafficking between the TGN and endosomes. Syntaxin-6 is also regulated by SHIP164 (syntaxin-6 Habc-interacting protein of 164 kDa) and the COG (conserved oligomeric Golgi) complex. SHIP164 binds directly to the Habc domain of syntaxin-6 and thereby regulates trafficking through the early/recycling endosomal system to the TGN . The COG complex also interacts with syntaxin-6 directly, via the Cog6 subunit and controls the steady-state levels of syntaxin-6 as well as those of the members of its cognate SNARE complex: syntaxin-16, Vti1a and VAMP4. The COG complex regulates syntaxin-6-dependent retrograde trafficking from the endosome to the TGN (Figure 2) .
Syntaxin-6-mediated intracellular cargo transport in various cell types
Specialized functions of syntaxin-6 in highly differentiated cell types have also been identified. In pancreatic β-cells, for example, syntaxin-6 is involved in regulated secretion during granule maturation as well as in retrograde endosomal trafficking of MPRs (mannose 6-phosphate receptors) to the lysosome and the TGN. Syntaxin-6 on clathrin-coated buds on IGs (immature granules) co-localizes with the AP-1 (activator protein 1) adaptor and accelerates the delivery of MPR to endosomes during secretory granule maturation [76,77].
In adipocytes, syntaxin-6 is involved in insulin-responsive protein trafficking. It is expressed on both the TGN and vesicles that contain Glut4 (glucose transporter type 4), an insulin-regulated transporter. Upon exposure of the cells to insulin, syntaxin-6 facilitates the transport of Glut4-containing vesicles to the plasma membrane. Moreover, functional inhibition of syntaxin-6 significantly reduces the rate of Glut4 re-internalization after insulin withdrawal and perturbs endosomal sorting of Glut4 (Figure 2) [57,78]. In adipocytes and myocytes, syntaxin-6 is also required for endocytic trafficking of IRAP (insulin-responsive aminopeptidase), a known enhancer of Glut4 exocytosis. Specifically, it stimulates retrograde transport of this protein from the plasma membrane to an IRC (insulin-responsive compartment) (Figure 2) [79,80].
As illustrated above, exocytosis is critical to the function of immune cells during inflammation. Syntaxin-6 has also been found to play an important role in immune cell exocytosis. In resting human neutrophils, syntaxin-6 is localized mainly in the plasma membrane, whereas SNAP-23 is located primarily in the SGs and the GGs . When neutrophils are activated, SNAP-23 is translocated to the plasma membrane and co-localizes with syntaxin-6 (Figure 2). Inhibiting SNAP-23 reduces Ca2+- and GTP-γ-S-induced exocytosis of CD67-enriched SGs, whereas the inhibition of syntaxin-6 prevents exocytosis of both CD67- and CD63-enriched granules. In activated macrophages, one of the major functions is to secrete pro-inflammatory cytokines such as TNFα (tumour necrosis factor α). Syntaxin-6 is up-regulated within a very short time period to meet the demand for TNFα trafficking and secretion. Since the up-regulation occurs rapidly, it is therefore likely that syntaxin-6 protein levels are regulated by post-translational or p53-mediated transcriptional mechanisms . These two SNAREs are present on intracellular membranes, isolated Golgi membranes and Golgi-derived TNFα vesicles, where they contribute to TNFα trafficking and secretion (Figure 2).
Finally, in a melanoma cell line, syntaxin-7 was expressed at very high levels and its overexpression may be involved in the biogenesis of melanosomes. In this cell type, syntaxin-6 forms a SNARE complex with syntaxin-7, mVti1b and VAMP7 or VAMP8, thereby regulating fusion events within the late endosomal pathway. These data suggest that syntaxin-6 SNARE complex plays a critical role in melanogenesis in normal melanocytes (Figure 2) . The specific roles of syntaxin-6 in a variety of cell types indicate that syntaxin-6 functions as an essential SNARE protein for maintenance of normal cellular homoeostasis and upon the activated physiological need of cells.
ROLE OF SYNTAXIN-6 IN ENDOTHELIAL-CELL DYNAMICS
ECs are specialized types of cells that line the interior surface of blood vessels and form the main barrier between the blood and the rest of the body. Unlike other cell types discussed above which require continuous active membrane transport events, the dynamic functions of ECs are activated only when angiogenesis is required. Angiogenesis is a physiological process that involves the growth of new blood vessels from pre-existing vessels, a process that requires dynamic cellular events such as cellular adhesion, proliferation and migration. These cellular events require an intracellular transport system that delivers crucial proteins involved in angiogenesis to the sites of their function. Impairment of the protein trafficking and delivery mechanisms causes endothelial dysfunction and is characteristic of many pathological and disease states such as atherosclerosis, diabetes, hypertension, inflammation and tumour metastasis [83,84]. Syntaxin-6 contributes to EC dynamics by regulating the trafficking of membrane-bound receptors in the EC that drives the physiological changes required for angiogenesis [69,85]. Recent reports from our group demonstrate that syntaxin-6 regulates angiogenesis by regulating the trafficking of VEGFR2 [VEGF(vascular endothelial growth factor) receptor 2] and the α5β1 integrin (Figure 2) [69,85]. Within the ECs, VEGFR2 is a key receptor tyrosine kinase present on the plasma membrane as well as on Golgi membranes whose function is regulated by transport from plasma membrane and secretory transport from the TGN. Studies by Manickam et al.  show that inhibition of syntaxin-6 in human ECs impairs the trafficking of the TGN pool of VEGFR2 and targets it to the lysosome for degradation. This work also demonstrated that the functional inhibition of syntaxin-6 reduced VEGF-dependent EC proliferation, migration and vascular tube formation . In addition to its role in the trafficking of VEGFR2, syntaxin-6 has also been shown to affect the angiogenesis process by modulating endocytic recycling of the α5β1 integrin . This integrin is one of the major adhesion molecules on ECs and plays an important role in adhesion and migration along the extracellular matrix during the angiogenic process. Tiwari et al.  demonstrate that the α5β1 integrin co-localizes with syntaxin-6 in EEA1-containing EEs and the inhibition of syntaxin-6 function causes misrouting of the α5β1 integrin to the degradation (against recycling) pathway via LEs and lysosomes (Figure 2). Furthermore, syntaxin-6 inhibition leads to a reduction in α5β1 integrin-dependent spreading on fibronectin and a reduction in Rac1 activation and altered Rac1 localization .
ROLE OF SYNTAXIN-6 IN HUMAN DISEASES
Many studies that have revealed the importance of syntaxin-6 in vital cellular events have also brought to light the relevance of syntaxin-6-dependent trafficking of key human disease-associated proteins. VEGF promotes angiogenesis by inducing signalling through VEGFR2. Work from several laboratories, including our own, suggests that syntaxin-6-mediated intracellular trafficking of VEGFR2 regulates angiogenesis. Functional inhibition of syntaxin-6 in vivo via adenoviral gene transfer of the inhibitory form of syntaxin-6 reduced VEGF-A-mediated angiogenesis in a mouse ear model . Taken together, these findings suggest that syntaxin-6 plays a critical role in regulating angiogenesis and could be a good target candidate for the development of anti-angiogenic therapies. The gene for syntaxin-6 has been shown to be a direct target of p53 and syntaxin-6 was found to promote cancer cell growth in a p53-dependent manner . In cancer cells, expressing p53 at wild-type levels, syntaxin-6 knockdown inhibited cell proliferation and survival and led to cell cycle arrest and apoptosis; however, syntaxin-6 knockdown in the presence of simultaneous p53 knockdown had no effect on cell growth. Syntaxin-6 may also play a role in CF (cystic fibrosis) as it is a component of the CAL [CFTR (CF transmembrane conductance regulator)-associated ligand] complex, which mediates lysosomal trafficking and degradation of the wild-type CFTR and temperature-rescued ΔF508-CFTR. In this context, syntaxin-6 regulates the abundance and function of post-ER (endoplasmic reticulum) localized wild-type CFTR . In addition, syntaxin-6 is found in the TGN of PC12 cells (derived from a transplantable rat pheochromocytoma) and moves to the distal tips of neurites upon stimulation with NGF (nerve growth factor). Thus, it may play a role in NGF-dependent neurite outgrowth, an important event in Parkinson's disease and AD . Interestingly, a very recent study also showed that genetic variation in syntaxin-6 is relevant to tauopathy (progressive supranuclear palsy), a movement disorder characterized by prominent tau neuropathology, a pathology commonly observed in AD . These studies emphasize the importance of syntaxin-6 not only in the maintenance of normal homoeostasis but also in pathological conditions.
Syntaxin-6 is involved in diverse cellular functions in a variety of cell types and has been shown to regulate many intracellular membrane trafficking events such as endocytosis, recycling and anterograde and retrograde trafficking. These in vitro studies in cells have enhanced the understanding of the role of syntaxin 6-containing SNARE complexes. However, future studies using animal models lacking syntaxin-6 will be needed to directly study the roles of this t-SNARE protein in various physiological and pathological processes.
CF transmembrane conductance regulator
central nervous system
conserved oligomeric Golgi
glucose transporter type 4
immature secretory granule
mannose 6-phosphate receptor
mature secretory granule
nerve growth factor
soluble N-ethylmaleimide-sensitive factor-attachment protein receptor
syntaxin-6 Habc-interacting protein of 164 kDa
23-kDa synaptosome-associated protein
25-kDA synaptosome-associated protein
tumour necrosis factor α
vesicle-associated membrane protein
vascular endothelial growth factor
VEGF receptor 2
vacuolar protein sorting 45
We apologize to colleagues whose works have not been directly cited owing to space limitations.
Our own work was supported by the National Institutes of Health, National Heart, Lung and Blood Institute [grant number HL089599] and the Department of Anatomy and Cell Biology, University of Iowa.